Lachkar B, Minaguchi T, Akiyama A, Liu S, Zhang S, Xu C, Shikama A, Tasaka N, Sakurai M, Nakao S, et al. Prognostic significance of PIK3CA mutation in stage IIB to IVA cervical cancers treated by concurrent chemoradiotherapy with weekly cisplatin. Medicine. 2018. 97. 31. e11392
S. M. Garland, P. Pitisuttithum, H. Y.S. Ngan, C. H. Cho, C. Y. Lee, C. A. Chen, Y. C. Yang, T. Y. Chu, N. F. Twu, R. Samakoses, et al. Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants from Asian Countries. Journal of Infectious Diseases. 2018. 218. 1. 95-108
Shuling Liu, Takeo Minaguchi, Bouchra Lachkar, Shuang Zhang, Chenyang Xu, Yuri Tenjimbayashi, Ayumi Shikama, Nobutaka Tasaka, Azusa Akiyama, Manabu Sakurai, et al. Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression. PLoS ONE. 2018. 13. 2. e0193061
Koji Matsumoto, Nobuo Yaegashi, Takashi Iwata, Kasumi Yamamoto, Minoru Nagashima, Toshiaki Saito, Kimio Ushijima, Fumiaki Takahashi, Kiichiro Noda, Hiroyuki Yoshikawa. Early impact of the Japanese immunization program implemented before the HPV vaccination crisis. INTERNATIONAL JOURNAL OF CANCER. 2017. 141. 8. 1704-1706
